Defense Of A Paradigm

Most of us in the Natural Philosophy Alliance who attended our Norman, Okla., meeting in late May, which you discussed in your May 15 issue [B. Goodman, The Scientist, page 3], thankful for the publicity, and admit that the writer made some effort to present a balanced discussion. Yet the result misrepresented us in several ways. First, I was the only person in our group cited, even though I urged the writer to cite others; and since I am, as he said, an unemployed academic, an impression of q

Written byJohn Chappell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Yet the result misrepresented us in several ways. First, I was the only person in our group cited, even though I urged the writer to cite others; and since I am, as he said, an unemployed academic, an impression of questionable competence was left. Yet like many others among us, I hold a Ph.D., have taught in universities (several still do), and have many scholarly publications. A few of us are widely honored experts, such as Ron Hatch, formerly of the Magnavox Corp. and winner of the Keppler Award, who should have been the one cited stating that the global positioning system offers no evidence in support of special or general relativity; and Grote Reber, principal founder of the science of radioastronomy, who has long argued firmly against Big Bang theory.

Secondly, it is incorrect that very few of us are physicists. Nearly all of us are: Some work as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies